摘要
Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
| 原文 | English |
|---|---|
| 專利號 | 8535674 |
| 出版狀態 | Published - 1800 |
指紋
Bone Neoplasms
Anti-Idiotypic Antibodies
Breast Neoplasms
Antibodies
interleukin 20
引用此文
@misc{9e8f51f094984c1194d7bbd9ba8737e6,
title = "Treating Breast Cancer and Inhibiting Cancer-Associated Bone Loss With Anti-IL-20 Antibody",
abstract = "Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.",
author = "Ming-Shi Chang",
year = "1800",
language = "English",
type = "Patent",
note = "8535674",
}
Treating Breast Cancer and Inhibiting Cancer-Associated Bone Loss With Anti-IL-20 Antibody. / Chang, Ming-Shi (Inventor).
專利號: 8535674.研究成果: Patent
TY - PAT
T1 - Treating Breast Cancer and Inhibiting Cancer-Associated Bone Loss With Anti-IL-20 Antibody
AU - Chang, Ming-Shi
PY - 1800
Y1 - 1800
N2 - Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
AB - Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
M3 - Patent
M1 - 8535674
ER -